Research ArticleNeuropharmacology
Open Access
Characterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin Gene‒Related Peptide Receptor
Eric Moore, Mark E. Fraley, Ian M. Bell, Christopher S. Burgey, Rebecca B. White, Chi-Chung Li, Christopher P. Regan, Andrew Danziger, Maria Stranieri Michener, Eric Hostetler, Pradeep Banerjee and Christopher Salvatore
Journal of Pharmacology and Experimental Therapeutics April 2020, 373 (1) 160-166; DOI: https://doi.org/10.1124/jpet.119.261065
Eric Moore
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, New Jersey (E.M., M.E.F., I.M.B., C.S.B., R.B.W., C.-C.L., C.P.R., A.D., M.S.M., E.H., C.S.) and Allergan plc, Madison, New Jersey (P.B.)
Mark E. Fraley
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, New Jersey (E.M., M.E.F., I.M.B., C.S.B., R.B.W., C.-C.L., C.P.R., A.D., M.S.M., E.H., C.S.) and Allergan plc, Madison, New Jersey (P.B.)
Ian M. Bell
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, New Jersey (E.M., M.E.F., I.M.B., C.S.B., R.B.W., C.-C.L., C.P.R., A.D., M.S.M., E.H., C.S.) and Allergan plc, Madison, New Jersey (P.B.)
Christopher S. Burgey
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, New Jersey (E.M., M.E.F., I.M.B., C.S.B., R.B.W., C.-C.L., C.P.R., A.D., M.S.M., E.H., C.S.) and Allergan plc, Madison, New Jersey (P.B.)
Rebecca B. White
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, New Jersey (E.M., M.E.F., I.M.B., C.S.B., R.B.W., C.-C.L., C.P.R., A.D., M.S.M., E.H., C.S.) and Allergan plc, Madison, New Jersey (P.B.)
Chi-Chung Li
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, New Jersey (E.M., M.E.F., I.M.B., C.S.B., R.B.W., C.-C.L., C.P.R., A.D., M.S.M., E.H., C.S.) and Allergan plc, Madison, New Jersey (P.B.)
Christopher P. Regan
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, New Jersey (E.M., M.E.F., I.M.B., C.S.B., R.B.W., C.-C.L., C.P.R., A.D., M.S.M., E.H., C.S.) and Allergan plc, Madison, New Jersey (P.B.)
Andrew Danziger
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, New Jersey (E.M., M.E.F., I.M.B., C.S.B., R.B.W., C.-C.L., C.P.R., A.D., M.S.M., E.H., C.S.) and Allergan plc, Madison, New Jersey (P.B.)
Maria Stranieri Michener
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, New Jersey (E.M., M.E.F., I.M.B., C.S.B., R.B.W., C.-C.L., C.P.R., A.D., M.S.M., E.H., C.S.) and Allergan plc, Madison, New Jersey (P.B.)
Eric Hostetler
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, New Jersey (E.M., M.E.F., I.M.B., C.S.B., R.B.W., C.-C.L., C.P.R., A.D., M.S.M., E.H., C.S.) and Allergan plc, Madison, New Jersey (P.B.)
Pradeep Banerjee
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, New Jersey (E.M., M.E.F., I.M.B., C.S.B., R.B.W., C.-C.L., C.P.R., A.D., M.S.M., E.H., C.S.) and Allergan plc, Madison, New Jersey (P.B.)
Christopher Salvatore
Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, New Jersey (E.M., M.E.F., I.M.B., C.S.B., R.B.W., C.-C.L., C.P.R., A.D., M.S.M., E.H., C.S.) and Allergan plc, Madison, New Jersey (P.B.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleNeuropharmacology
Characterization of Ubrogepant: A CGRP Receptor Antagonist
Eric Moore, Mark E. Fraley, Ian M. Bell, Christopher S. Burgey, Rebecca B. White, Chi-Chung Li, Christopher P. Regan, Andrew Danziger, Maria Stranieri Michener, Eric Hostetler, Pradeep Banerjee and Christopher Salvatore
Journal of Pharmacology and Experimental Therapeutics April 1, 2020, 373 (1) 160-166; DOI: https://doi.org/10.1124/jpet.119.261065
Research ArticleNeuropharmacology
Characterization of Ubrogepant: A CGRP Receptor Antagonist
Eric Moore, Mark E. Fraley, Ian M. Bell, Christopher S. Burgey, Rebecca B. White, Chi-Chung Li, Christopher P. Regan, Andrew Danziger, Maria Stranieri Michener, Eric Hostetler, Pradeep Banerjee and Christopher Salvatore
Journal of Pharmacology and Experimental Therapeutics April 1, 2020, 373 (1) 160-166; DOI: https://doi.org/10.1124/jpet.119.261065
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement